ASST

Victory Capital Holdings (VCTR) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.65 per share. This compares to earnings of $1.36 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +10.64%. A quarter ago, it was expected that this investment management firm would post earnings of $1.66 per share when it actually produced earnings of $1.78, delivering a surprise of +7.23%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Victory Capital, which belongs to the Zacks Financial - Investment Management industry, posted revenues of $387.99 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 5.16%. This compares to year-ago revenues of $219.6 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Victory Capital shares have added about 28.8% since the beginning of the year versus the S&P 500's gain of 6%. While Victory Capital has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Victory Capital was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can s...

CAMPBELL, Calif., Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in conjunction with its third quarter 2025 financial results. Semler Scientific intends to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025, on or about November 12, 2025. About Semler Scientific, Inc.: Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and is a leader in medical devices and software to combat chronic diseases. By using proceeds from equity and debt financings, as well as cash flows from operations, Semler Scientific intends to strategically accumulate Bitcoin. In addition, through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc., develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. Additional information about Semler Scientific can be found at www.semlerscientific.com. Cautionary Statement Regarding Forward-Looking Statements Certain statements herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Rule 175 promulgated thereunder, and Section 21E of the Exchange Act and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements regarding filing of the third quarter Form 10-Q of Semler Scientific, Inc. (Semler Scientific), the outlook and expectations of Strive, Inc. (Strive) and Semler Scientific, respectively, with respect to the proposed transaction, the strategic benefits and financial benefits of th...

Revenue: US$633.5k (up 129% from FY 2023). Net loss: US$6.45m (loss widened by 31% from FY 2023). US$1.70 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Asset Entities shares are down 5.2% from a week ago. We don't want to rain on the parade too much, but we did also find 6 warning signs for Asset Entities that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.